Alex F. Herrera
City Of Hope National Medical Center(US)City of Hope(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Cancer Immunotherapy and Biomarkers, CNS Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial(2018)2,184 cited
- → Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma(2019)748 cited
- → Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity(2020)335 cited
- → Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma(2017)318 cited
- → Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial(2022)270 cited
- → Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis(2016)227 cited
- → 5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1)(2023)218 cited
- → Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results(2021)203 cited
- → Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation(2016)185 cited
- → PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation(2019)178 cited